Intelligence coverage: 65%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

PROF

Profound Medical Corp.

Healthcare · Medical Instruments & Supplies

$5.74Sep 23, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Profound Medical Corp. shows accelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +25% YoY in Q2 FY2026.

TrajectoryAccelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

  • Revenue +25% YoY in Q2 FY2026

Pipeline evidence · 17d ago

AlphaOS Signals
Upgrade to Premium

Latest earnings · Q2 2026

Full PROF earnings analysis

Reported figures for Profound Medical Corp. — research only, not investment advice.

Revenue YoY
+25.3%
EPS YoY
-150.0%

Latest Intelligence

Updated

What happened recently for Profound Medical Corp. (PROF) — events, not interpretation.

Event
Reported Q2 2026 revenue +25% YoY.
Also
Last session September 23, 2026 at $5.74.
Source
Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Profound Medical Corp. (PROF)

Healthcare · Medical Instruments & Supplies

Investment Snapshot above is the primary AlphaOS analysis for Profound Medical Corp. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Market cap:
$209.51M
Revenue:
$2.48M

PROF earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Profound Medical Corp. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Profound Medical Corp. (PROF) in AlphaOS research

Connected companies and research pages from the AlphaOS knowledge graph.